Outcomes of patients with metastatic clear-cell renal cell carcinoma treated with second-line VEGFR-TKI after first-line immune checkpoint inhibitors
一线免疫检查点抑制剂治疗后接受二线VEGFR-TKI治疗的转移性透明细胞肾细胞癌患者的预后
期刊:European Journal of Cancer
影响因子:7.1
doi:10.1016/j.ejca.2019.04.003
Shah, A Y; Kotecha, R R; Lemke, E A; Chandramohan, A; Chaim, J L; Msaouel, P; Xiao, L; Gao, J; Campbell, M T; Zurita, A J; Wang, J; Corn, P G; Jonasch, E; Motzer, R J; Sharma, P; Voss, M H; Tannir, N M
肿瘤
肿瘤免疫
肾癌
EGF
EGFR
细胞生物学
VEGF
免疫/内分泌